Parkside Financial Bank & Trust Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Parkside Financial Bank & Trust

  • $621 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 10, 2021
SELL
$64.07 - $91.75 $11,917 - $17,065
-186 Closed
0 $0
Q4 2020

Feb 09, 2021
SELL
$65.07 - $98.24 $4,164 - $6,287
-64 Reduced 25.6%
186 $16,000
Q3 2020

Nov 06, 2020
BUY
$59.04 - $77.95 $1,948 - $2,572
33 Added 15.21%
250 $16,000
Q2 2020

Aug 10, 2020
BUY
$29.01 - $74.23 $6,295 - $16,107
217 New
217 $16,000

Others Institutions Holding BHVN

# of Institutions
11
Shares Held
785K
Call Options Held
0
Put Options Held
0
View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

BHVN Quotes by TradingView
  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $3.65B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track Parkside Financial Bank & Trust Portfolio

Follow Parkside Financial Bank & Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkside Financial Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Parkside Financial Bank & Trust with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email